RECURRENT GLIOSARCOMA
Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Modified brain cells tested to boost chemo against aggressive tumors
Disease control OngoingThis early-stage study is testing a new two-part treatment for aggressive brain tumors that have returned after standard therapy. Doctors place genetically modified neural stem cells into the brain to make the tumor more sensitive to a chemotherapy drug called irinotecan. The mai…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug combo tested in fight against deadly brain cancer
Disease control TerminatedThis study is testing a new two-part treatment for aggressive brain tumors that have returned or worsened. It aims to see if giving the drugs GI-102 and pembrolizumab just before surgery is safe and can help the immune system attack the tumor. The trial is for adults with specifi…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC